UK MHRA wants medtech comments on payment for free sale certs
This article was originally published in Clinica
The UK Medicines and Healthcare Products Regulatory Agency is inviting feedback from medical device manufacturers on its plans to introduce a fee for processing each certificate of free sale (CFS) application as of April 2015.
You may also be interested in...
The EU network of health technology assessment bodies says it is seeing the benefit of systematically involving patients when companies approach it for early scientific advice on evidence generation.
Stay up to date on regulatory guidelines from around the world with the Pink Sheet's Guidance Tracker. The complete Global Pharma Guidance Tracker, with sortable and searchable listings going back to 2014, is available online.
Stay current on regulatory guidelines from around the world with Medtech Insight's Guidance Tracker. Twenty-eight guidance documents have been posted on the tracker since its last update.